Commons Sense

House of Commons · Written Ministerial Statement

Hereditary Tyrosinemia Type 1

11 March 2024 · Department of Health and Social Care

Proposed by Andrew Stephenson Con Pendle

NHS

Summarised by AI from the official record, so it can contain mistakes.

View on Parliament.uk

At a glance

Key points

  • The UK National Screening Committee recommended adding Hereditary Tyrosinemia Type 1 to the New-born Bloodspot Screening Programme in England.
  • The Written Ministerial Statement accepts the recommendation to include Hereditary Tyrosinemia Type 1 in the screening programme.
  • NHS England will commence implementation work for the addition next year.

Issue summary

The statement discusses the introduction of Hereditary Tyrosinemia Type 1 into the New-born Bloodspot Screening Programme in England.

Action requested

I have accepted the recommendation by the UK National Screening Committee to introduce Hereditary Tyrosinemia type 1 to the programme, ensuring fairer access to early diagnosis and treatment. NHS England is beginning implementation work for this addition next year.

Key facts

  • Hereditary Tyrosinemia Type 1 affects about seven babies in the UK annually.
  • The condition can lead to severe complications if left untreated.
  • Early screening allows for more effective treatment before symptoms appear.
▸ Assessment & feedback
Summary accuracy